Chemoautotrophic cells comprising an engineered carbon fixation pathway
Curt R. Fischer, Boston, MA (US); Austin J. Che, Boston, MA (US); Reshma P. Shetty, Boston, MA (US); and Jason R. Kelly, Boston, MA (US)
Assigned to Ginkgo Bioworks, Inc., Boston, MA (US)
Filed by Ginkgo Bioworks, Inc., Boston, MA (US)
Filed on Jul. 30, 2020, as Appl. No. 16/943,819.
Application 16/943,819 is a continuation of application No. 15/867,209, filed on Jan. 10, 2018, granted, now 10,801,045.
Application 15/867,209 is a continuation of application No. 14/354,354, granted, now 9,902,980, previously published as PCT/US2012/062540, filed on Oct. 30, 2012.
Application 14/354,354 is a continuation in part of application No. 13/285,919, filed on Oct. 31, 2011, granted, now 8,349,587.
Prior Publication US 2021/0010037 A1, Jan. 14, 2021
1. A chemoautotrophic host cell that comprises a heterologous polynucleotide encoding a hexulose-6-phosphate synthase (HPS), wherein the polynucleotide comprises a sequence that is at least 90% identical to SEQ ID NO: 46 or 47.